Molecular Fishing

Phage Display Technology fundamentally involves fusing foreign peptide or protein genes with a phage coat protein gene. During propagation, the foreign protein is displayed on the surface of phage particles, creating a Phage Library (the "Fish Pond"). Simultaneously, the encoding DNA is packaged within the particle, establishing a physical link between "Phenotype" and "Genotype". Specific target molecules ("Bait") are then used to screen the Phage Library, isolating sequences with high affinity to the target ("Fish that Bite the Bait").

Fig 1 Phage Display Technology[1]

Phage Display Technology holds significant potential in immunology and drug development. This article details a standard Phage Display Technology protocol using the commonly employed filamentous phage M13, covering key steps: library construction, affinity selection (biopanning), phage amplification and purification, and positive clone screening and identification.

Library Construction

Vector Preparation

Digest the vector plasmid with restriction enzymes to linearize it and remove small fragments.

Insert Preparation

Amplify the target gene fragment via PCR and digest it with appropriate restriction enzymes.

Ligation

Mix purified linearized vector and insert fragments at an optimized ratio. Perform the ligation reaction using DNA ligase.

Transformation

Electroporate the ligation product into highly competent F' host bacteria.

Primary Library Amplification and Storage

Plate transformed cells on Amp-containing agar plates for overnight growth. Harvest all colonies by scraping and resuspend in glycerol-supplemented medium. Store at -80°C (as a bacterial library).

Biopanning

This process enriches phage clones binding specifically to a target. Solid-phase Biopanning serves as the example:

Basic Workflow

Fig 2 Biopanning[1]

Phage Library Preparation

Add helper phage to superinfect the stored bacterial library. Incubate overnight to generate the primary phage library. Determine the phage titer (pfu/mL).

Coating

Immobilize the target molecule onto a suitable solid support (e.g., immunotube, ELISA plate well, magnetic beads).

Blocking

Block remaining sites on the solid phase using BSA or skim milk to suppress non-specific binding.

Binding

Incubate the purified phage library with the coated support, allowing specific phage binding.

Washing

Wash repeatedly with buffer to remove unbound and non-specifically bound phage.

Elution

Recover specifically bound phage from the solid phase.

Neutralization

Neutralize acidic or alkaline elution buffers immediately.

Selection Rounds

Typically perform 3 to 5 rounds of Biopanning. Infect fresh F' host bacteria with the eluted phage. Amplify using helper phage, then purify the resulting phage for use as input in the next round[2]. Record input and output (eluted) titers for each round. A significant increase in the enrichment factor (output titer / input titer) indicates successful selection.

Positive Clone Screening and Identification

Single-Clone Phage Preparation

Infect host bacteria with phage from the final biopanning round. Plate on Amp-containing agar for single colonies after overnight growth.

Primary Screening

Phage ELISA

Pick single colonies (96). Culture in Amp-medium, add helper phage, and prepare single-clone phage supernatants. Incubate supernatants separately in wells coated with target antigen and control protein (e.g., BSA). After washing, sequentially add anti-M13 antibody, enzyme-conjugated secondary antibody, and substrate. A significant increase in OD value for antigen wells compared to control wells identifies positives.

Spot Blot/Colony PCR

Serve as rapid alternative primary screening methods.

Positive Clone Identification

For confirmed positives, purify the displayed protein or express soluble protein. Determine binding affinity using techniques like Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI), or ELISA titration[3].

Summary and Outlook

Phage Display Technology is a powerful and versatile screening tool. Its success critically depends on well-designed protocols and meticulous execution.

Key considerations include:

(i) Maintaining strict aseptic technique throughout to prevent phage/bacterial contamination.
(ii) Continuously monitoring library diversity and titer to ensure library quality.
(iii) Optimizing coating, blocking, and washing conditions to minimize non-specific phage binding.
(iv) Preserving the native conformation and activity of the target molecule during coating and binding steps.

Alpha Lifetech possesses an advanced Phage Display Technology platform. We provide high-quality, custom phage display library construction services to help clients accurately and rapidly obtain high-affinity and specific antibodies or ligands against specific targets.

FAQ

1. During the construction of a Phage Display Library, how can library diversity and size be maximized?

Achieving high library size and diversity is fundamental. Ligation efficiency impacts the proportion of functional recombinants, while transformation efficiency directly determines the number of recombinant DNA molecules introduced into bacteria.

Ligation:
(i) Optimize the molar ratio of insert to vector (determined through pre-experiment).
(ii) Utilize high-efficiency ligase with strict control of ligation temperature and duration.
(iii) Purify ligation products to remove unligated vector and insert fragments.

Transformation (commonly electroporation):
(i) Use electrocompetent cells with high transformation efficiency (>10^10 cfu/µg DNA).
(ii) Strictly adhere to electroporator parameters and pre-cooling electroporation cuvette and cells.
iii) Ligated products must be highly purified and at moderate concentration to avoid excessive salts.
(iv) Add pre-warmed recovery medium immediately after electroporation for adequate outgrowth.

Determine library size immediately after outgrowth by serial dilution and plating. The target library size must significantly exceed the theoretical diversity.
2. During the panning process, how can blocking and washing steps be optimized to minimize non-specific binding without losing potentially weak binders?

Blocking agents block non-specific adsorption sites; washing removes unbound and weakly bound phage. Employing a gradient washing strategy mimics affinity maturation by progressively increasing selection pressure.

Blocking Agent Selection & Optimization:
(i) Common blockers include 2-5% BSA (skim milk may contain biotin, interfering with streptavidin systems) or 1-5% Casein. Pre-experiment are needed to compare effectiveness.
(ii) Block for at least 1 hour; overnight at 4°C is optimal. Ensure complete coverage of all potential non-specific binding sites.

Washing Stringency Strategy:
(i) Perform gentle washing in the first round (e.g., 3-5 washes with PBST/TBST) to retain maximum binders, including weak binders.
(ii) Gradually increase stringency in subsequent rounds (more washes; introduce competitors; brief high-salt washes) to enrich high-affinity clones and eliminate weak/non-specific binders.
(iii) After each round, determine the titer of eluted phage (Output) and compare it to the titer from a non-coated well (Input). An increasing Output/Input ratio indicates effective enrichment.
3. After several rounds of panning, how can successful enrichment of target-binding clones be assessed?

Rising Output titers indicate phage enrichment but cannot distinguish target-specific from non-specific binding. Phage ELISA on individual clones assesses the binding specificity of the enriched phage population to the target antigen.

Single-Clone Phage ELISA:
Randomly pick 96 single clones from the Output phage pool of each panning round. Culture small volumes, harvest phage supernatants, and test binding to the target antigen versus a negative antigen.

Successful enrichment is indicated when:
(i) Signal in the target antigen well is significantly higher than in the negative control well.
(ii) Both the proportion of positive signals and their intensity increase markedly with successive panning rounds.
4. When screening single clones from an enriched library for binding validation, what efficient and reliable methods exist? How can missing valuable clones be avoided?

Single-clone validation is key for identifying specific binders; soluble fragment validation provides more precise characterization later. Single-Clone Phage ELISA is the standard method, offering high throughput for testing multiple targets or controls.

Soluble Binding Fragment Assays include:
(i) Prokaryotic Expression (e.g., Fab/scFv-His/Flag):
Subclone scFv/Fab genes from the display vector into an expression vector. Induce soluble protein fragment expression. Detect binding via His/Flag tags using ELISA, BLI, or SPR.
* Advantage: Eliminates phage particle background; allows direct affinity measurement.
* Disadvantage: Relatively lower throughput.

(ii) Colony/Phage Lift:
Spot transformed or infected bacterial colonies onto a membrane. After induction and cell lysis, expressed protein fragments bind to the membrane. Detect positive clones using labeled antigen.
* Advantage: High throughput and speed; suitable for initial large-scale screening.
* Disadvantage: Lower quantification and specificity.
5. How should a phage display library be properly stored to ensure long-term stability and activity?

Primary methods are:
(i) Glycerol Stock Library: Grow bacteria harboring the phagemid to mid-log phase. Add glycerol to a final concentration of 15-25%, mix thoroughly, aliquot into multiple small tubes (to avoid repeated freeze-thaw cycles), and store at -80°C.
(ii) Lyophilized Phage Particles: Lyophilize purified phage suspension (supplemented with high concentrations of cryoprotectant). Lyophilized powder can be stored long-term at 4°C or room temperature (protected from light and moisture) with minimal activity loss. Reconstitute using sterile water or buffer.

reference

[1] Mujahed I M, Ahmed M. Developing recombinant antibodies by phage display technology to neutralize viral infectious diseases[J]. SLAS Discovery, Volume 29, Issue 3, 2024, 100140.

[2] Oscar M G, Marta B, Morten K D S, et al. Deep mining of antibody phage-display selections using Oxford Nanopore Technologies and Dual Unique Molecular Identifiers[J]. New Biotechnology, Volume 80, 2024, 56-68.

[3] Stacey E C, Pablo G, Anna A, et al. Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library[J]. SLAS Discovery, Volume 31, 2025, 100216.